Zobrazeno 1 - 10
of 30
pro vyhledávání: '"João D Barros-Silva"'
Autor:
Maria J Camões, Paula Paulo, Franclim R Ribeiro, João D Barros-Silva, Mafalda Almeida, Vera L Costa, Nuno Cerveira, Rolf I Skotheim, Ragnhild A Lothe, Rui Henrique, Carmen Jerónimo, Manuel R Teixeira
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e49819 (2012)
FLI1 and ERG, the major ETS transcription factors involved in rearrangements in the Ewing's sarcoma family of tumors (ESFT) and in prostate carcinomas (PCa), respectively, belong to the same subfamily, having 98% sequence identity in the DNA binding
Externí odkaz:
https://doaj.org/article/3f287445533d4b2a9279c0c11708fc2d
Autor:
Franclim R Ribeiro, Paula Paulo, Vera L Costa, João D Barros-Silva, João Ramalho-Carvalho, Carmen Jerónimo, Rui Henrique, Guro E Lind, Rolf I Skotheim, Ragnhild A Lothe, Manuel R Teixeira
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e22317 (2011)
A large percentage of prostate cancers harbor TMPRSS2-ERG gene fusions, leading to aberrant overexpression of the transcription factor ERG. The target genes deregulated by this rearrangement, however, remain mostly unknown. To address this subject we
Externí odkaz:
https://doaj.org/article/35096269b807436484e8aab535a5939d
Autor:
Celina Whalley, Andrew D Beggs, Oliver J Pickles, Rachel Hoare, Kasun Wanigasooriya, Tortieju Sillo, Mohammed E. El-Asrag, Robert Tyler, Louise Tee, Tariq Ismail, João D. Barros-Silva, Agata Stodolna, Joanne D. Stockton, Christopher Yau, Claire Bryer
Partial or total resistance to preoperative chemoradiotherapy occurs in more than half of locally advanced rectal cancer patients. Several novel or repurposed drugs have been trialled to improve cancer cell sensitivity to radiotherapy, with limited s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30f360ef6663cfb090a839265b85f193
https://doi.org/10.1101/2021.08.31.458326
https://doi.org/10.1101/2021.08.31.458326
Autor:
Rachel Wheat, João D. Barros-Silva, Andrew D Beggs, Celina Whalley, Mark P Dilworth, Jonathan James, Thomas Nieto, Ian Geh, Joanne D. Stockton, Louise Tee
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 16, Iss 1, Pp 1-12 (2021)
Radiation Oncology, Vol 16, Iss 1, Pp 1-12 (2021)
Background Pathological complete response (pathCR) in rectal cancer is beneficial, as up to 75% of patients do not experience regrowth of the primary tumour, but it is poorly understood. We hypothesised that the changes seen in the pre-treatment biop
Autor:
Robert Tyler, Tariq Ismail, Andrew D Beggs, Kasun Wanigasooriya, João D. Barros-Silva, Yashashwi Sinha
Publikováno v:
Cancers, Vol 12, Iss 1278, p 1278 (2020)
Cancers
Cancers
Radiotherapy is routinely used as a neoadjuvant, adjuvant or palliative treatment in various cancers. There is significant variation in clinical response to radiotherapy with or without traditional chemotherapy. Patients with a good response to radio
Autor:
Maria P. Silva, João D. Barros-Silva, Elin Ersvær, Wanja Kildal, Tarjei Sveinsgjerd Hveem, Manohar Pradhan, Joana Vieira, Manuel R. Teixeira, Håvard E. Danielsen
Publikováno v:
Translational Oncology, Vol 9, Iss 6, Pp 575-582 (2016)
Overtreatment is a major concern in men diagnosed with prostate cancer. The aim of this study was to evaluate the combined prognostic role of three frequent molecular alterations in prostate cancer, namely relative 8q gain, ERG overexpression, and lo
Autor:
Tarjei S. Hveem, Manuel R. Teixeira, Maria P. Silva, Joana Vieira, Elin Ersvær, Håvard E. Danielsen, Manohar Pradhan, Wanja Kildal, João D. Barros-Silva
Publikováno v:
Translational Oncology. 9:575-582
Overtreatment is a major concern in men diagnosed with prostate cancer. The aim of this study was to evaluate the combined prognostic role of three frequent molecular alterations in prostate cancer, namely relative 8q gain, ERG overexpression, and lo
Autor:
João D. Barros-Silva, Jenny Antonello, Ged Brady, Adnan Ali, Alession Cannistraci, Hui Sun Leong, Caroline Dive, Esther Baena, Jonathan H Shanks, Valentina Ubertini, Noel W. Clarke, Thomas Hambrock, Marina Parry, Vijay A C Ramani, Shambhavi Srivastava, Daisuke Nonaka, Richard Marais, Crispin J. Miller, Pedro Oliveira, Maurice W Lau, Nathalie Dhomen
Publikováno v:
Ali, S A 2018, ' Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and-nonvisible Lesions in Clinically Localised Prostate Cancer ', European Urology Oncology . https://doi.org/10.1016/j.euo.2018.08.005
BackgroundThe prostate cancer (PCa) diagnostic pathway is undergoing a radical change with the introduction of multiparametric magnetic resonance imaging (mpMRI), genomic testing, and different prostate biopsy techniques. It has been proposed that th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72447d3fa487f701edea2cfcd03de964
https://eprints.gla.ac.uk/214548/1/214548.pdf
https://eprints.gla.ac.uk/214548/1/214548.pdf
Autor:
Noel W. Clarke, Esther Baena, Guo-Cheng Yuan, Ivana Steiner, Douglas E. Linn, Garry Ashton, Hubert Pakula, Isabel Peset, Roderick T. Bronson, Zhe Li, Stuart H. Orkin, Adnan Ali, Guoji Guo, João D. Barros-Silva, Michael D Brown
Publikováno v:
Barros-Silva, J D, Linn, D E, Steiner, I, Guo, G, Ali, A, Pakula, H, Ashton, G, Peset, I, Brown, M, Clarke, N W, Bronson, R T, Yuan, G-C, Orkin, S H, Li, Z & Baena, E 2018, ' Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer ', Cell Reports, vol. 25, no. 12, pp. 3504-3518.e6 . https://doi.org/10.1016/j.celrep.2018.11.069
Cell Reports
Cell Reports, Vol 25, Iss 12, Pp 3504-3518.e6 (2018)
Cell Reports
Cell Reports, Vol 25, Iss 12, Pp 3504-3518.e6 (2018)
Summary The exact identity of castrate-resistant (CR) cells and their relation to CR prostate cancer (CRPC) is unresolved. We use single-cell gene profiling to analyze the molecular heterogeneity in basal and luminal compartments. Within the luminal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::973d65a8592483a3258d28e0348b6ae7
https://doi.org/10.1016/j.celrep.2018.11.069
https://doi.org/10.1016/j.celrep.2018.11.069
Autor:
Ana Teresa Martins, Rui Henrique, Maria P. Silva, Lurdes Torres, Paula Paulo, Joana Vieira, Márcia Vieira-Coimbra, Susana Lisboa, Cecília Correia, Manuel R. Teixeira, João D. Barros-Silva, Carmen Jerónimo
Publikováno v:
Genes, Chromosomes and Cancer. 55:365-374
Prostate carcinomas harboring 8q gains are associated with poor clinical outcome, but the target genes of this genomic alteration remain to be unveiled. In this study, we aimed to identify potential 8q target genes associated with clinically aggressi